News Image

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting

Provided By GlobeNewswire

Last update: Mar 26, 2025

Fort Lee, NJ, March 26, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP900 at the upcoming 2025 American Association for Cancer Research Meeting (2025 AACR), taking place from April 25th to April 30th in Chicago, IL. Presentation details are below:

Read more at globenewswire.com

NUVECTIS PHARMA INC

NASDAQ:NVCT (6/9/2025, 8:00:02 PM)

After market: 8.85 0 (0%)

8.85

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more